-
FDA Recommends Approval of Muraglitazar, But May Need To Reconsider; Which Antipsychotics Are More Dangerous?; Should CPOE Undergo Evaluation?; New Treatment for Tennis Elbow; FDA Actions
-
-
Fabry disease must be considered in all cases of unexplained stroke in young patients, especially in those with the combination of infarction in the vertebrobasilar artery system and proteinuria.
-
In patients with an ischemic stroke, a normal carotid DUS examination does not support the routine use of TEE to exclude the presence of complex aortic arch plaque or thrombi.
-
Patent foramen ovale is commonly associated with cryptogenic stroke, but there is inadequate evidence in the medical literature to support the use of transcatheter closure devices ...
-
A long term placebo controlled study is now needed to establish whether cannabinoids may have a role beyond symptom amelioration in MS.
-
Modafinil failed to significantly improve EDS in PD compared with placebo.
-
A small but significant number of patients with unrecognized ALS undergo spinal surgery that in retrospect may be inappropriate.
-
The strong correlation between reduction of aura symptoms and migraine attacks stresses the potential role of aura-like events.
-
'Idiopathic' RBD patients with olfactory impairment might present with stage 2 preclinical alpha-synucleinopathy.